Horizon Pharma to buy Raptor Pharma for $800 million

September 12, 2016 11:54 AM

17 0

Horizon Pharma Plc (HZNP.O) said it has agreed to buy Raptor Pharmaceutical Corp (RPTP.O) for nearly $800 million to strengthen its portfolio of rare disease drugs.

The specialty pharmaceutical company said it would offer $9 per Raptor share, which is a 21 percent premium to Raptor's Friday close.

Also read: Groups partner to increase lagging US orchestra diversity

Read more

To category page